NIH clinical trial testing antiviral remdesivir plus antiiInflammatory drug baricitinib for COVID-19 began
On May 8, 2020, the NIH announced that a randomized, controlled clinical trial evaluating the safety and efficacy…
The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients
On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
The CoVIg-19 Plasma Alliance was established
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies or COVID-19 therapy
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) under its flagship programme NMITLI announced…
Biotechnology | CDC | COVID-19 | FDA
Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assay
On May 8, 2020, Quidel announced it had received Emergency Use Authorization (EUA) from the FDA to market…
AbbVie completed acquisition of Allergan for nearly $62 billion
On May 8, 2020, AbbVie announced it had completed its acquisition of Allergan following receipt of regulatory approval…
OPKO Health’s BioReference Laboratories launched COVID-19 antibody screening for New York City residents
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
Biotechnology | COVID-19 | Life Science News | Nanotechnology | Pharmaceutical | Therapeutics | Vaccine
Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
The Defense Health Agency collaborated to further sequence the SARS-CoV-2 code
On May 7, 2020, the Defense Health Agency announced that the Air Force Genetics Center of Excellence at…
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 7, 2020, the FDA approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell…
COVID-19 in-home monitoring program launched
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
NIH-supported research examines impact of COVID-19 on rare diseases community
On May 7, 2020, the NIH announced a new online survey launched by the NIH-supported Rare Diseases Clinical…
Risk factors for COVID-19 death revealed in worldï¾’s largest analysis of patient records to date
On May 7, 2020, academics at the University of Oxford and the London School of Hygiene & Tropical…
Sanger scientist received Chan Zuckerberg Initiative support for COVID-19 study
On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of…
Biotechnology | COVID-19 | Diagnostics | Genomics | Life Science News | Non-Profit Research | Therapeutics
Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms
On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…
Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
UNMC researcher one of 12 in US to receive grant to study heart health related to COVID-19
On May 7, 2020, Rebekah Gundry, Ph.D., was one of only 12 investigators nationwide to receive a “COVID-19…
Catalent partnered with Humanigen to support FDA approved phase 3 lenzilumab study for COVID-19
On May 7, 2020, Catalent announced Phase 3 study for lenzilumab, the companyï¾’s proprietary Humaneeredï¾® anti-human granulocyte macrophage-colony…
Tonix Pharma announced a research collaboration and exclusive agreement with the University of Alberta to develop novel c-based vaccines for prevention of COVID-19
On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…
First large study of hydroxychloroquine does not support routine use in COVID-19 patients
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
CoVIg-19 Plasma Alliance builds strong momentum through expanded membership and clinical trial collaboration
On May 7, 2020, the CoVId-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the…
Baxter announced results of clinical trial on benefits of Dynamic Fluid Management in septic shock patients
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
New freeze-resistant trichinella species discovered in wolverines
On May 6, 2020, the U.S. Dept. of Agriculture (USDA) announced that a new freeze-resistant Trichinella species had…
Sinovac announced first animal study results of vaccine against COVID-19 published in SCIENCE
On May 6, 2020, Sinovac Biotech announced publication of the preclinical study on animals for its vaccine candidate…
Miami University confirmed high quality of IGEA’s COVID-19 rapid test
On May 6, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…